Steris earnings were $434.8M for the trailing 12 months ending Sep 30, 2024, with -20.4% growth year over year. The latest STE earnings report on Sep 30, 2024 announced Q3 2024 earnings of $150.0M, up 3.2% from last quarter. For the last reported fiscal year 2024 ending Mar 31, 2024, STE reported annual earnings of $378.2M, with 253.4% growth.
STE past earnings growth
How has STE's earnings growth performed historically?
On STE's earnings call on Invalid Date, Steris (NYSE: STE) reported Q3 2024 earnings per share (EPS) of $1.52, up 29.91% year over year. Total STE earnings for the quarter were $150.03 million. In the same quarter last year, Steris's earnings per share (EPS) was $1.17.
As of the last Steris earnings report, Steris is currently profitable. Steris's net profit (also called net income) for the twelve months ending Sep 30, 2024 was $434.80 million, a 20.93% decrease year over year.
What was STE's earnings growth in the past year?
As of Steris's earnings date in Invalid Date, Steris's earnings has grown -20.43% year over year. This is 59.09 percentage points lower than the US Medical Devices industry earnings growth rate of 38.66%. STE earnings in the past year totalled $434.80 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.